Patent · US Active

Improving trabeculectomy outcome by administering an anti-placental growth factor antibody

US9089552B2 · kind B2 · utility

0Cited by

14References

19Claims

0Family size

Assignee

ThromboGenics NV · BE

Inventors

Bart Jonckx · Oud-Heverlee, BE
Tine Van Bergen · Hoogstraten, BE
Ingeborg Stalmans · Knokke, BE

Key dates

Filing date	Mar 13, 2013
Grant date	Jul 28, 2015
Priority date	—
Expiry date	Mar 13, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The current invention relates to the improvement of trabeculectomy surgery. The improvement more specifically resides in an extended lifetime of the sclera-corneal drainage channel created by trabeculectomy surgery. The improvement is obtained by post-surgical administration of an anti-PlGF antibody or fragment thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.